South & Central America Regenerative Medicines Market Size and Forecast (2021 - 2031)
The regenerative medicine market in South and Central America is poised for significant growth, with projections indicating that its size will expand from approximately US$ 413.5 million in 2024 to an impressive US$ 1,434.7 million by 2031. This growth trajectory reflects a compound annual growth rate (CAGR) of 19.6% from 2025 to 2031, driven by various factors that underscore the increasing demand for regenerative treatments in the region.
The market is primarily segmented into key countries, including Brazil, Argentina, and the broader South and Central America region. A notable driver of this market expansion is the rising prevalence of chronic diseases, which is becoming a pressing concern in these countries. Additionally, the region is witnessing a surge in medical tourism, particularly in Argentina and Brazil, where patients seek advanced treatments that may not be available in their home countries. Government initiatives aimed at supporting research and development in cell and gene therapies further bolster the market's growth potential.
Demographic trends also play a crucial role in shaping the regenerative medicine landscape. The population aged over 65 in South and Central America is expected to double by 2050, with Brazil and Chile experiencing significant increases. This aging demographic is particularly vulnerable to chronic conditions such as dementia and osteoarthritis. According to the Alzheimer's Association, over 55 million people globally are living with dementia, and Latin America is facing an escalating burden due to its aging population. In Brazil alone, osteoarthritis affected over 12 million individuals in 2020, highlighting the urgent need for effective treatments. Regenerative therapies, including stem cell treatments for osteoarthritis and gene therapies for neurodegenerative disorders, are gaining traction as they address the root causes of tissue degeneration, offering hope for patients and healthcare providers alike.
To capitalize on the growing market, companies are adopting various business strategies, including collaborations and geographical expansion. A notable example is Geistlich's recent agreement to acquire Bionnovation Biomedical, a medical technology company in Brazil. This acquisition allows Geistlich to enhance its regenerative product portfolio, providing affordable and reliable solutions to clinicians and patients across Latin America and other emerging markets.
The South and Central America regenerative medicines market can be segmented by product type, application, and specific therapies. By product type, the market includes cell-based products, gene therapy, and tissue engineering, with tissue engineering holding the largest market share in 2024. Within cell-based products, stem cell therapies are leading the way. In terms of applications, oncology is the dominant segment, followed by neurological disorders, wound healing, ophthalmology, orthopedics, immunology, and genetic disorders.
The integration of precision medicine into regenerative therapies is a transformative trend that enhances treatment effectiveness by tailoring interventions to individual patients' genetic, molecular, and cellular profiles. This approach not only improves safety and efficacy but also paves the way for innovative treatments that can restore or replace damaged tissues and organs. As precision regenerative medicine evolves, it addresses the underlying causes of diseases while considering individual variations in genetics and lifestyle, leading to the development of advanced therapies such as CAR-T cell treatments and CRISPR gene editing.
Emerging startups are also contributing to the market by focusing on the precision delivery of regenerative proteins and cellular therapies. For instance, Orio Therapeutics is innovating therapeutic proteins that enhance drug delivery to damaged tissues, while StemBio is processing human-derived stem cells for orthopedic and urological applications. Technologies like Lamina Therapeutics' 3D biodegradable wound dressings, which incorporate patient-derived stem cells, exemplify the shift towards personalized regenerative solutions.
Country-wise, Brazil is the largest market in the region, driven by a high incidence of chronic diseases. Cardiovascular diseases account for about 30% of annual deaths in Brazil, with a reported 9% annual increase in diagnosed cases from 2020 to 2023. The Brazilian National Cancer Institute estimates that around 600,000 new cancer cases are diagnosed each year, with common types including breast, prostate, and lung cancers. The rising prevalence of dementia, with over 1.2 million Brazilians affected in 2023, further emphasizes the need for effective regenerative therapies.
The Brazilian government, alongside private sector investments, is increasingly funding research and development in regenerative medicine. Initiatives such as technology transfer agreements aim to produce affordable gene therapies locally, enhancing access to innovative treatments. The growth of medical tourism and the expansion of healthcare infrastructure in Brazil are also facilitating the adoption of these advanced therapies.
Key players in the regenerative medicines market include major pharmaceutical companies such as Novartis, Bristol-Myers Squibb, Johnson & Johnson, and Takeda Pharmaceutical, among others. These companies are actively pursuing strategies such as product innovation, market expansion, and mergers and acquisitions to enhance their market presence and deliver cutting-edge solutions to consumers.
In summary, the regenerative medicine market in South and Central America is on a robust growth path, driven by demographic changes, increasing chronic disease prevalence, and advancements in medical technology. The combination of government support, innovative therapies, and strategic collaborations positions this market as a promising sector in the healthcare landscape.
The market is primarily segmented into key countries, including Brazil, Argentina, and the broader South and Central America region. A notable driver of this market expansion is the rising prevalence of chronic diseases, which is becoming a pressing concern in these countries. Additionally, the region is witnessing a surge in medical tourism, particularly in Argentina and Brazil, where patients seek advanced treatments that may not be available in their home countries. Government initiatives aimed at supporting research and development in cell and gene therapies further bolster the market's growth potential.
Demographic trends also play a crucial role in shaping the regenerative medicine landscape. The population aged over 65 in South and Central America is expected to double by 2050, with Brazil and Chile experiencing significant increases. This aging demographic is particularly vulnerable to chronic conditions such as dementia and osteoarthritis. According to the Alzheimer's Association, over 55 million people globally are living with dementia, and Latin America is facing an escalating burden due to its aging population. In Brazil alone, osteoarthritis affected over 12 million individuals in 2020, highlighting the urgent need for effective treatments. Regenerative therapies, including stem cell treatments for osteoarthritis and gene therapies for neurodegenerative disorders, are gaining traction as they address the root causes of tissue degeneration, offering hope for patients and healthcare providers alike.
To capitalize on the growing market, companies are adopting various business strategies, including collaborations and geographical expansion. A notable example is Geistlich's recent agreement to acquire Bionnovation Biomedical, a medical technology company in Brazil. This acquisition allows Geistlich to enhance its regenerative product portfolio, providing affordable and reliable solutions to clinicians and patients across Latin America and other emerging markets.
The South and Central America regenerative medicines market can be segmented by product type, application, and specific therapies. By product type, the market includes cell-based products, gene therapy, and tissue engineering, with tissue engineering holding the largest market share in 2024. Within cell-based products, stem cell therapies are leading the way. In terms of applications, oncology is the dominant segment, followed by neurological disorders, wound healing, ophthalmology, orthopedics, immunology, and genetic disorders.
The integration of precision medicine into regenerative therapies is a transformative trend that enhances treatment effectiveness by tailoring interventions to individual patients' genetic, molecular, and cellular profiles. This approach not only improves safety and efficacy but also paves the way for innovative treatments that can restore or replace damaged tissues and organs. As precision regenerative medicine evolves, it addresses the underlying causes of diseases while considering individual variations in genetics and lifestyle, leading to the development of advanced therapies such as CAR-T cell treatments and CRISPR gene editing.
Emerging startups are also contributing to the market by focusing on the precision delivery of regenerative proteins and cellular therapies. For instance, Orio Therapeutics is innovating therapeutic proteins that enhance drug delivery to damaged tissues, while StemBio is processing human-derived stem cells for orthopedic and urological applications. Technologies like Lamina Therapeutics' 3D biodegradable wound dressings, which incorporate patient-derived stem cells, exemplify the shift towards personalized regenerative solutions.
Country-wise, Brazil is the largest market in the region, driven by a high incidence of chronic diseases. Cardiovascular diseases account for about 30% of annual deaths in Brazil, with a reported 9% annual increase in diagnosed cases from 2020 to 2023. The Brazilian National Cancer Institute estimates that around 600,000 new cancer cases are diagnosed each year, with common types including breast, prostate, and lung cancers. The rising prevalence of dementia, with over 1.2 million Brazilians affected in 2023, further emphasizes the need for effective regenerative therapies.
The Brazilian government, alongside private sector investments, is increasingly funding research and development in regenerative medicine. Initiatives such as technology transfer agreements aim to produce affordable gene therapies locally, enhancing access to innovative treatments. The growth of medical tourism and the expansion of healthcare infrastructure in Brazil are also facilitating the adoption of these advanced therapies.
Key players in the regenerative medicines market include major pharmaceutical companies such as Novartis, Bristol-Myers Squibb, Johnson & Johnson, and Takeda Pharmaceutical, among others. These companies are actively pursuing strategies such as product innovation, market expansion, and mergers and acquisitions to enhance their market presence and deliver cutting-edge solutions to consumers.
In summary, the regenerative medicine market in South and Central America is on a robust growth path, driven by demographic changes, increasing chronic disease prevalence, and advancements in medical technology. The combination of government support, innovative therapies, and strategic collaborations positions this market as a promising sector in the healthcare landscape.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. REGENERATIVE MEDICINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. REGENERATIVE MEDICINES MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Regenerative Medicines Market Revenue (US$ Million), 2024 - 2031
6.2 South & Central America Regenerative Medicines Market Forecast and Analysis
7. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
7.1 Cell Based Products
7.1.1 Overview
7.1.2 Cell Based Products: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Tissue Engineering
7.3.1 Overview
7.3.2 Tissue Engineering: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET REVENUE ANALYSIS - BY CELL BASED PRODUCTS - PRODUCTS TYPE
8.1 Stem Cell
8.1.1 Overview
8.1.2 Stem Cell: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Cell Based Immuno Therapy
8.2.1 Overview
8.2.2 Cell Based Immuno Therapy: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET REVENUE ANALYSIS - BY APPLICATION
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Neurological Disorders
9.2.1 Overview
9.2.2 Neurological Disorders: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Wound Healing and Skin Regeneration
9.3.1 Overview
9.3.2 Wound Healing and Skin Regeneration: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Ophthalmology
9.4.1 Overview
9.4.2 Ophthalmology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Orthopedics and Musculoskeletal
9.5.1 Overview
9.5.2 Orthopedics and Musculoskeletal: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Genetic Disorders
9.7.1 Overview
9.7.2 Genetic Disorders: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET - COUNTRY ANALYSIS
10.1 South & Central America
10.1.1 South & Central America Regenerative Medicines Market Revenue and Forecast and Analysis - by Country
10.1.1.1 South & Central America Regenerative Medicines Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Brazil: South & Central America Regenerative Medicines Market Share - by Product Type
10.1.2.2.2 Brazil: South & Central America Regenerative Medicines Market Share - by Cell Based Products - Products Type
10.1.2.2.3 Brazil: South & Central America Regenerative Medicines Market Share - by Application
10.2.3.3 Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Argentina: South & Central America Regenerative Medicines Market Share - by Product Type
10.2.3.3.2 Argentina: South & Central America Regenerative Medicines Market Share - by Cell Based Products - Products Type
10.2.3.3.3 Argentina: South & Central America Regenerative Medicines Market Share - by Application
10.3.4.4 Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 Rest of South & Central America: South & Central America Regenerative Medicines Market Share - by Product Type
10.3.4.4.2 Rest of South & Central America: South & Central America Regenerative Medicines Market Share - by Cell Based Products - Products Type
10.3.4.4.3 Rest of South & Central America: South & Central America Regenerative Medicines Market Share - by Application
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Novartis AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bristol-Myers Squibb Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson & Johnson
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Takeda Pharmaceutical Co Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioMarin Pharmaceutical Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 JCR Pharmaceuticals Co. Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Daiichi Sankyo Co Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Vertex Pharmaceuticals Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CSL Behring LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Bluebird Bio Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Ferring Pharmaceuticals
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Japan Tissue Engineering Co., Ltd.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. REGENERATIVE MEDICINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. REGENERATIVE MEDICINES MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Regenerative Medicines Market Revenue (US$ Million), 2024 - 2031
6.2 South & Central America Regenerative Medicines Market Forecast and Analysis
7. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
7.1 Cell Based Products
7.1.1 Overview
7.1.2 Cell Based Products: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Tissue Engineering
7.3.1 Overview
7.3.2 Tissue Engineering: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET REVENUE ANALYSIS - BY CELL BASED PRODUCTS - PRODUCTS TYPE
8.1 Stem Cell
8.1.1 Overview
8.1.2 Stem Cell: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Cell Based Immuno Therapy
8.2.1 Overview
8.2.2 Cell Based Immuno Therapy: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET REVENUE ANALYSIS - BY APPLICATION
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Neurological Disorders
9.2.1 Overview
9.2.2 Neurological Disorders: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Wound Healing and Skin Regeneration
9.3.1 Overview
9.3.2 Wound Healing and Skin Regeneration: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Ophthalmology
9.4.1 Overview
9.4.2 Ophthalmology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Orthopedics and Musculoskeletal
9.5.1 Overview
9.5.2 Orthopedics and Musculoskeletal: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Genetic Disorders
9.7.1 Overview
9.7.2 Genetic Disorders: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. SOUTH & CENTRAL AMERICA REGENERATIVE MEDICINES MARKET - COUNTRY ANALYSIS
10.1 South & Central America
10.1.1 South & Central America Regenerative Medicines Market Revenue and Forecast and Analysis - by Country
10.1.1.1 South & Central America Regenerative Medicines Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Brazil: South & Central America Regenerative Medicines Market Share - by Product Type
10.1.2.2.2 Brazil: South & Central America Regenerative Medicines Market Share - by Cell Based Products - Products Type
10.1.2.2.3 Brazil: South & Central America Regenerative Medicines Market Share - by Application
10.2.3.3 Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Argentina: South & Central America Regenerative Medicines Market Share - by Product Type
10.2.3.3.2 Argentina: South & Central America Regenerative Medicines Market Share - by Cell Based Products - Products Type
10.2.3.3.3 Argentina: South & Central America Regenerative Medicines Market Share - by Application
10.3.4.4 Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 Rest of South & Central America: South & Central America Regenerative Medicines Market Share - by Product Type
10.3.4.4.2 Rest of South & Central America: South & Central America Regenerative Medicines Market Share - by Cell Based Products - Products Type
10.3.4.4.3 Rest of South & Central America: South & Central America Regenerative Medicines Market Share - by Application
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Novartis AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bristol-Myers Squibb Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson & Johnson
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Takeda Pharmaceutical Co Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioMarin Pharmaceutical Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 JCR Pharmaceuticals Co. Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Daiichi Sankyo Co Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Vertex Pharmaceuticals Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 CSL Behring LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Bluebird Bio Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Ferring Pharmaceuticals
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Japan Tissue Engineering Co., Ltd.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. South & Central America Regenerative Medicines Market Segmentation
Table 2. List of Vendors
Table 3. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 5. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cell Based Products - Products Type
Table 6. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 7. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 9. Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cell Based Products - Products Type
Table 10. Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 11. Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 12. Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cell Based Products - Products Type
Table 13. Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 14. Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 15. Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cell Based Products - Products Type
Table 16. Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 17. Heat Map Analysis by Key Players
Table 1. South & Central America Regenerative Medicines Market Segmentation
Table 2. List of Vendors
Table 3. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 5. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cell Based Products - Products Type
Table 6. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 7. South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 9. Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cell Based Products - Products Type
Table 10. Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 11. Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 12. Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cell Based Products - Products Type
Table 13. Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 14. Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 15. Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cell Based Products - Products Type
Table 16. Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 17. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. South & Central America Regenerative Medicines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. South & Central America Regenerative Medicines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Regenerative Medicines Market Revenue (US$ Million), 2024 - 2031
Figure 7. South & Central America Regenerative Medicines Market Share (%) - by Product Type, 2024 and 2031
Figure 8. Cell Based Products: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Gene Therapy: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Tissue Engineering: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. South & Central America Regenerative Medicines Market Share (%) - by Cell Based Products - Products Type, 2024 and 2031
Figure 12. Stem Cell: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Cell Based Immuno Therapy: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. South & Central America Regenerative Medicines Market Share (%) - by Application, 2024 and 2031
Figure 15. Oncology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Neurological Disorders: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Wound Healing and Skin Regeneration: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Ophthalmology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Orthopedics and Musculoskeletal: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Immunology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Genetic Disorders: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Others: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South & Central America Regenerative Medicines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 24. Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Company Positioning & Concentration
Figure 1. South & Central America Regenerative Medicines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. South & Central America Regenerative Medicines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Regenerative Medicines Market Revenue (US$ Million), 2024 - 2031
Figure 7. South & Central America Regenerative Medicines Market Share (%) - by Product Type, 2024 and 2031
Figure 8. Cell Based Products: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Gene Therapy: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Tissue Engineering: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. South & Central America Regenerative Medicines Market Share (%) - by Cell Based Products - Products Type, 2024 and 2031
Figure 12. Stem Cell: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Cell Based Immuno Therapy: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. South & Central America Regenerative Medicines Market Share (%) - by Application, 2024 and 2031
Figure 15. Oncology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Neurological Disorders: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Wound Healing and Skin Regeneration: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Ophthalmology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Orthopedics and Musculoskeletal: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Immunology: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Genetic Disorders: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Others: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South & Central America Regenerative Medicines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 24. Brazil: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Argentina: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Rest of South & Central America: South & Central America Regenerative Medicines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Company Positioning & Concentration
